Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05512650 · ClinicalTrials.gov registry record · NA
Virtual Reality and Meditation for Fibromyalgia
A NA study, sponsored by Tufts University.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT05512650 is a NA study that has completed, run by Tufts University. The registered enrollment target is 9 participants.
The verdict
NCT05512650, a NA study, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Fibromyalgia (FM) is a particularly debilitating rheumatological syndrome which affects millions of adults in the United States. The condition presents with widespread chronic muscular pain and reduced pain thresholds, fatigue, insomnia, and negative affect. Chronic pain that is caused by FM can have significant effects on physical function, psychological parameters, and overall quality of life. Currently, there is a need for safe and effective non-pharmacologic pain-management strategies for FM, and research has shown that virtual reality (VR) may be a useful tool for some of these clients. The literature has suggested improvements in pain scores on a visual analog scale (VAS) for adults with a variety of rheumatological issues, including FM. Additional research has demonstrated that affect was improved for clients with FM who participated in a 10-minute VR mindfulness session. Such findings highlight the potential benefits of VR and mindfulness meditation for clients with FM. However, there is a great deal that remains unknown about the effectiveness of these pain management techniques. Therefore, this pilot study will examine and compare the effectiveness of combining VR and meditation for improving symptoms of FM in adults. We hypothesize that a VR meditation session will facilitate greater improvements in pain, affect, and physiological vital stats as compared to a non-immersive meditation intervention.
Interventions
- DEVICE Virtual Reality Meditation
- DEVICE Non-VR Meditation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2022-05-31 |
| Est. Completion | 2022-08-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05512650
The ClinicalTrials.gov registry entry for NCT05512650 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Virtual Reality Meditation is the first listed.
NCT05512650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05512650 about?
NCT05512650 is a clinical study titled "Virtual Reality and Meditation for Fibromyalgia". Fibromyalgia (FM) is a particularly debilitating rheumatological syndrome which affects millions of adults in the United States. The condition presents with widespread chronic muscular pain and reduced pain thresholds, fatigue, insomnia, and negative affect. Chronic pain that is caused by FM can hav...
What is the current status of trial NCT05512650?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2022-05-31. Estimated completion is 2022-08-02.
What interventions are being tested in trial NCT05512650?
The interventions under investigation include: Virtual Reality Meditation (DEVICE), Non-VR Meditation (DEVICE).
Who is sponsoring clinical trial NCT05512650?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.